We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Sekisui Diagnostics UK Ltd.

Download Mobile App




Patient-Reported Outcomes Available at Point-of-Care

By HospiMedica International staff writers
Posted on 29 Dec 2014
Print article
A new partnership enables oncology providers to easily gather and view patient reported outcome (PRO) data at the point of care (POC).

The integration of the Vector Oncology (Memphis, TN, USA) Patient Care Monitor and the Flatiron Health (New York, NY, USA) OncoEMR cloud-based electronic medical record (EMR) is intended to provide oncology care providers with additional insights needed to support quality of life and alleviate symptom burden for cancer patients. The Patient Care Monitor is a web-based technology platform that collects data from patients at the POC, including 86 physical symptoms across treatment side effects, impairment, acute distress, and despair and depression.

Flatiron Health and Vector Oncology will also collaborate on various studies involving health outcomes and economic endpoints in support of clinical research efforts and real-world evidence generation. In addition, Lee Schwartzberg, MD, president and chief medical officer for Vector Oncology, will serve as a medical advisor to Flatiron Health, thus helping to leverage PRO data with Flatiron's EMR platform in order to merge technology in the support of the oncology community and achieve meaningful improvements in cancer care.

“The integration of Flatiron's OncoEMR with our Patient Care Monitor will create an unmatched source of real world clinical and patient reported outcomes intelligence to improve the quality of cancer care and demonstrate the effectiveness and value of treatments,” said Mike Choukas, CEO of Vector Oncology.

“We are excited to partner with Vector Oncology, as we share a similar goal of leveraging technology to improve the quality of cancer care for patients,” said Nat Turner, co-founder and CEO of Flatiron Health. “This alliance will enable us to further support oncology providers with additional insights at the point of care.”

Related Links:

Vector Oncology
Flatiron Health


Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Silver Member
Compact 14-Day Uninterrupted Holter ECG
NR-314P
New
Oxidized Zirconium Implant Material
OXINIUM

Print article

Channels

Surgical Techniques

view channel
Image: Miniaturized electric generators based on hydrogels for use in biomedical devices (Photo courtesy of HKU)

Hydrogel-Based Miniaturized Electric Generators to Power Biomedical Devices

The development of engineered devices that can harvest and convert the mechanical motion of the human body into electricity is essential for powering bioelectronic devices. This mechanoelectrical energy... Read more

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.